---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-000973"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2026-05-27T20:39:45+00:00"
generated_at: "2026-05-27T20:43:22.302773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences launches $6.53M ATM program; Craft Capital files FINRA claim for $880K

## Summary
- Entered at-the-market offering agreement with H.C. Wainwright to sell up to $6.53M of common stock, with 3.0% commission.
- Shelf registration (Form S-3) effective May 19, 2026; ATM prospectus supplement filed May 26, 2026.
- Craft Capital Management filed FINRA arbitration claim alleging breach of right of first refusal; seeks $880K success fee, warrants valued at $880K, plus late fees.
- Company terminated engagement with Craft on March 27, 2026 and closed private placement of ~$11M on March 30, 2026.

## SEC filing metadata
- accession: 0001640334-26-000973
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2026-05-27T20:39:45+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000973/0001640334-26-000973-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033426000973/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-000973
- JSON: https://secwatch.observer/filing/0001640334-26-000973.json
- Plain text: https://secwatch.observer/filing/0001640334-26-000973.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.